Do insulin resistance and high triglycerides increase triglyceride-rich VLDL production and drive higher LDL particle number and small dense LDL formation?

The relationship between insulin resistance, triglyceride metabolism, and the formation of atherogenic low-density lipoprotein (LDL) particles is well-established through metabolic kinetic studies and clinical observations.

Clinical and effectiveness evidence

Clinical data, including findings from the Framingham Offspring Study and other large cohorts, demonstrate a strong positive correlation between plasma triglycerides and both LDL particle number (LDL-P) and small dense LDL (sdLDL) concentration (r ≈ 0.4–0.6, p < 0.001). In patients with insulin resistance, the overproduction of very low-density lipoprotein (VLDL) leads to a predictable shift in the lipid profile characterized by "Pattern B," where smaller, denser LDL particles predominate even if total LDL cholesterol (LDL-C) remains within a normal range.

Mechanistic explanations

The progression from insulin resistance to increased LDL particle number involves a two-stage metabolic cascade:

• VLDL Overproduction: Insulin resistance in the liver and adipose tissue leads to selective signaling defects. While insulin fails to suppress glucose production, it hyper-stimulates de novo lipogenesis via the SREBP-1c pathway. Simultaneously, insulin resistance in adipose tissue increases the flux of free fatty acids to the liver. This provides the substrate for the liver to secrete large, triglyceride-enriched VLDL1 particles. Each VLDL particle contains one molecule of apolipoprotein B (ApoB).
• Lipoprotein Remodeling: Once in circulation, these triglyceride-rich VLDL particles interact with LDL through the action of Cholesteryl Ester Transfer Protein (CETP). CETP facilitates an exchange where VLDL "trades" triglycerides to LDL in return for cholesteryl esters. The now triglyceride-enriched LDL particles become targets for Hepatic Lipase (HL), which hydrolyzes the triglycerides. This process shrinks the LDL particles, increasing their density and resulting in the formation of small dense LDL.

Bottom line

The claim is strongly supported by science. Insulin resistance drives the hepatic overproduction of triglyceride-rich VLDL, which directly fuels the creation of a higher number of smaller, more atherogenic LDL particles through CETP-mediated lipid exchange and enzymatic remodeling.